Clinical trial Recruiting at 1 site Interventional Ages 55 and up

Nurse-led daily weight tracking to improve heart failure self-care and quality of life

Official title: The Effect of a Nurse-led Daily Weight Monitoring Intervention (Wake and Weigh) on Heart Failure Quality of Life and Self-care

Run by The Cleveland Clinic · NCT07184541 · Data updated 2026-11-12

This pilot will try a simple nurse-led 'Wake and Weigh' weight tracking tool to see if it helps adults 55 and older with heart failure improve self-care and quality of life.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment42 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Avon, Ohio)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedOctober 31, 2026
Study endsDecember 2026
Registry record updatedSeptember 24, 2025
Trial IDNCT07184541 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults aged 55 or older who are hospitalized for heart failure, can stand and weigh independently, and have or can obtain a home scale.

Probably not a fit

Patients with documented cognitive impairment, a Charlson Comorbidity Index above 4, who cannot stand or weigh independently, or who cannot complete follow-up are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled pilot comparing a nurse-led daily weight monitoring tool called Wake and Weigh with usual care in adults aged 55 and older hospitalized for heart failure. Participants complete the Self-Care in Heart Failure Index and the Kansas City Cardiomyopathy Questionnaire at admission and four weeks after discharge to capture self-care behaviors and symptom-related quality of life. The trial will measure feasibility and intervention fidelity, including how consistently nurses deliver the tool and whether participants use it after discharge. Findings will be used to refine methods for a larger definitive randomized trial.

Why it matters

Potential benefit: If successful, the intervention could help patients detect fluid changes earlier, strengthen daily self-care habits, and potentially reduce symptom burden and hospital readmissions.

How similar studies have gone: Daily weight monitoring and nurse-led self-care support have been tested previously with mixed results—some programs lowered readmissions while others showed limited benefit—so this simplified Wake and Weigh approach is a relatively modest and pragmatic refinement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults (55 years or older)
2. New or existing diagnosis of HF (regardless of type or length of time since diagnosis).
3. Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet).
4. Must be able to read and communicate in English.
5. Must be able to stand and weigh independently.
6. Must have a scale at home, or ability to obtain one for the study.

Exclusion Criteria:

1. Documented diagnosis of cognitive impairment.
2. A Charlson Comorbidity Index (CCI) of \>4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of \>3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI \>2 (Foraker et al., 2014).

Where it's running

  • Cleveland Clinic Avon Hospital
    Avon, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.